LGVNLongeveron Inc.

Nasdaq longeveron.com


$ 2.23 $ -0.25 (-10.2 %)    

Friday, 21-Jun-2024 15:53:16 EDT
QQQ $ 480.84 $ -1.29 (-0.27 %)
DIA $ 391.56 $ -0.73 (-0.19 %)
SPY $ 544.47 $ -0.73 (-0.13 %)
TLT $ 93.96 $ 0.00 (0 %)
GLD $ 214.79 $ -3.38 (-1.55 %)
$ 2.2
$ 2.41
$ 0.00 x 0
$ 0.00 x 0
$ 2.20 - $ 2.42
$ 0.77 - $ 37.80
1,644,139
na
13.97M
$ 0.52
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 02-27-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-11-2023 06-30-2023 10-Q
5 05-12-2023 03-31-2023 10-Q
6 03-14-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-12-2022 06-30-2022 10-Q
9 05-13-2022 03-31-2022 10-Q
10 03-11-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-13-2021 06-30-2021 10-Q
13 05-14-2021 03-31-2021 10-Q
14 03-30-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 whats-going-on-with-longeveron-stock

Longeveron shares are trading higher Thursday, and the stock is up more than 200% this week. Here's a look at what's go...

 longeveron-shares-resume-trade
Longeveron Shares Resume Trade
06/13/2024 14:13:05

Core News & Articles
Market-Moving News for June 13th
06/13/2024 12:28:13

TSLA: 7% | Tesla Bull Gary Black Sees Elon Musk's $56B Pay Package Pass 'Easily' At Shareholder Meeting; Expects St...

 why-are-longeveron-shares-trading-higher-wednesday

Longeveron Inc. (NASDAQ: LGVN) shares are moving higher on Wednesday afternoon following the circulation of a Zacks Small Cap R...

 watching-longeveron-zacks-small-cap-research-issues-1510-price-valuation-says-longeveron-is-focusing-on-using-its-primary-treatment-lomecel-b-to-fight-a-rare-pediatric-heart-birth-defect-that-devastates-families-announced-the-completion-of-an-encouraging-meeting-with-investigators-involved-in-the-ongoing-trial-of-lomecel-b-for-the-treatment-of-hlhs

https://scr.zacks.com/files/News/2024/Zacks_SCR_Research_06122024_LGVN_Sorensen.pdf

 longeveron-completes-successful-investigator-meeting-for-on-going-phase-2b-clinical-trial-evaluating-lomecel-b-as-potential-treatment-for-hlhs-rare-pediatric-cardiac-disease

Longeveron® Announces Completion of Successful Investigator Meeting for On-going Phase 2b Clinical Trial Evaluating Lomecel-B™ ...